Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for preparing natural myeloperoxidase from neutrophil azurophilic granules of human blood

A myeloperoxidase and neutrophil technology, which is applied in the fields of biotechnology and immunology, can solve the problems of unknown antigen contamination and no ANCA antigens, and achieve increased enrichment and relative purity, specificity and stability. The effect of improving performance and efficiency

Pending Publication Date: 2018-09-28
武汉博百欧生物科技有限公司
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

After isolation, no other known trace ANCA antigens (PR3, BPI) were found, but contamination with other unknown antigens is unknown

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing natural myeloperoxidase from neutrophil azurophilic granules of human blood
  • Method for preparing natural myeloperoxidase from neutrophil azurophilic granules of human blood
  • Method for preparing natural myeloperoxidase from neutrophil azurophilic granules of human blood

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] Example 1: Method for Isolating and Purifying Natural Myeloperoxidase from Human Blood Neutrophil Azurophilic Granules

[0044] 1. White blood cell extraction

[0045] 1) Add anticoagulant to 2.76L blood and mix gently;

[0046] 2) Place the test tube upright at room temperature or in an incubator at 37°C for 30-60 minutes, and wait for the red blood cells to settle naturally; at this time, it can be seen that the suspension in the test tube is divided into 3 layers, the upper layer is light yellow plasma, and the bottom layer is red blood cells. There is a gray white layer of white blood cells on the layer.

[0047] 3) Use a capillary to absorb the leukocyte-rich cell suspension above the red blood cell layer, and transfer it to another test tube;

[0048] 4) Add Ca-free 2+ , Mg 2+ Hank's solution was placed at a distance of 3 cm from the mouth of the test tube, mixed evenly, centrifuged in a horizontal centrifuge at 2000 r / min for 10 min, discarded the supernatant...

Embodiment 2

[0079] Embodiment 2: The purity verification of the myeloperoxidase (MPO) antigen that embodiment 1 extracts and purifies

[0080] In this example, the purity of the myeloperoxidase (MPO) antigen extracted and purified in Example 1 was verified, and a parallel experiment was carried out using the purified MPO antigen from Yashraj Biotechnology Company of India. The verification method is polyacrylamide gel electrophoresis (SDS-PAGE), stained with Coomassie blue, scanned by BioRad's ChemiDoc MP imager, and densitometry analysis of the results of the electrophoresis gel. Test results such as Figure 11 As shown, it can be clearly seen from this protein glue result that the MPO antigen purified by India Yashraj Biotechnology company has the situation of suspected small molecular weight impurities or protein degradation, and the myeloperoxidase (MPO) antibody extracted and purified by the technical scheme of the present invention Principles have features such as higher purity and...

Embodiment 3

[0081] Embodiment 3: the specific verification of the myeloperoxidase (MPO) antigen that embodiment 1 extracts and purifies

[0082] This example verified the specificity of the method for extracting and purifying the MPO antigen in Example 1. The MPO antigen obtained in Example 1 was used as the standard antigen to measure the titer of the antibody in the serum samples of 13 samples. Parallel comparison experiments were carried out with the MPO antigen. The verification method adopted the ELISA (enzyme-linked immunoassay) method, and the 13 samples tested included 7 normal serum samples and 6 positive serum samples. The test results are shown in Table 5:

[0083] Table 5 The specificity verification of the myeloperoxidase (MPO) antigen that the present invention extracts and purifies

[0084]

[0085] As can be seen from the above table, the natural myeloperoxidase extracted and purified by the method of the present invention is compared with the myeloperoxidase extracte...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention relates to the field of biotechnologies and immunology, and particularly relates to a method for preparing natural myeloperoxidase from neutrophil azurophilic granules of human blood. According to the method, through a research on the biochemical characteristics of the natural myeloperoxidase, a primary leukocyte tissue fluid extraction process is improved through a mode of increasing cell tissue separation and an extraction and regrinding mode of target tissues, so that the enrichment degree and the relative purity of chromatographic premyeloperoxidase can be substantially improved. Then, a perfect and reasonable chromatographic method is combined to reduce the yield loss of the myeloperoxidase subjected to chromatography, so that the whole purification process is more suitable for batch production. A series of high-specification quality detection shows that the yield, the purity, the activity, the specificity and the stability of a natural myeloperoxidase antigen produced by the process are all substantially improved; with high quality, the natural myeloperoxidase is more suitable for medical detection and scientific research.

Description

technical field [0001] The invention relates to the fields of biotechnology and immunology, in particular to a method for preparing natural myeloperoxidase from human blood neutrophil azurophilic granules. Background technique [0002] Antineutrophil cytoplasmic antibodies (ANCA) are autoantibodies directed against the cytoplasmic components of neutrophils and monocytes. Most of these antibodies are of the IgG type, and there is a clear positive reaction in the indirect immunofluorescence (IFA) reaction of ethanol-fixed neutrophils and monocytes, and one of their main targets is myeloperoxidase (MPO ) antigen (the so-called perinuclear p-ANCA). The purified myeloperoxidase (MPO) antigen can be used for detection of anti-myeloperoxidase (MPO) autoantibodies in immunoassay, immunochemical and biochemical MPO studies. Anti-myeloperoxidase (MPO) antibodies are one of the important serological hallmarks of certain systemic vascular diseases and are associated with idiopathic mi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N9/08
CPCC12N9/0065C12Y111/02002
Inventor 孙鹏康雅明
Owner 武汉博百欧生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com